Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effimia Cycle Control and Tolerability Study in Italy
NCT06067256Phase 4Recruiting
- Sponsor
- Italfarmaco
- Start
- Jul 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norgestimate + ethinyl estradiol in contraception, sponsored by Italfarmaco. Started Jul 2023; status: recruiting.
02
Drugs
norgestimate + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT06067256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06067256.